Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial

Author:

Desai Madhav1ORCID,Ausk Karlee2,Brannan Donald2,Chhabra Rajiv3ORCID,Chan Walter4ORCID,Chiorean Michael2ORCID,Gross Seth A.5,Girotra Mohit2ORCID,Haber Gregory5ORCID,Hogan Reed B.6ORCID,Jacob Bobby7ORCID,Jonnalagadda Sreeni3,Iles-Shih Lulu2,Kumar Navin4ORCID,Law Joanna8ORCID,Lee Linda4,Lin Otto8,Mizrahi Meir7,Pacheco Paulo5ORCID,Parasa Sravanthi2ORCID,Phan Jennifer9,Reeves Vonda6,Sethi Amrita10,Snell David5,Underwood James6,Venu Nanda8,Visrodia Kavel10,Wong Alina2,Winn Jessica1,Wright Cindy Haden6,Sharma Prateek1ORCID

Affiliation:

1. Department of Gastroenterology, Kansas City VA Medical Center, Kansas City, Missouri, USA;

2. Gastroenterology, Swedish Health and Swedish Medical Center, Seattle, Washington, USA;

3. Department of Gastroenterology, Saint Luke's Hospital of Kansas City, Kansas City, Missouri, USA;

4. Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA;

5. Gastroenterology, New York University Langone Health, New York, New York, USA;

6. GI Associates and Endoscopy Center, Jackson, Mississippi, USA;

7. Gastroenterology, Largo Medical Center, Largo, Florida, USA;

8. Gastroenterology, Virginia Mason Franciscan Health, Seattle, Washington, USA;

9. Departement of Gastroenterology, Keck Medicine University of Southern California, Los Angeles, California, USA;

10. Department of Gastroenterology, Columbia University Irving Medical Center, New York, New York, USA.

Abstract

INTRODUCTION: Adenoma per colonoscopy (APC) has recently been proposed as a quality measure for colonoscopy. We evaluated the impact of a novel artificial intelligence (AI) system, compared with standard high-definition colonoscopy, for APC measurement. METHODS: This was a US-based, multicenter, prospective randomized trial examining a novel AI detection system (EW10-EC02) that enables a real-time colorectal polyp detection enabled with the colonoscope (CAD-EYE). Eligible average-risk subjects (45 years or older) undergoing screening or surveillance colonoscopy were randomized to undergo either CAD-EYE–assisted colonoscopy (CAC) or conventional colonoscopy (CC). Modified intention-to-treat analysis was performed for all patients who completed colonoscopy with the primary outcome of APC. Secondary outcomes included positive predictive value (total number of adenomas divided by total polyps removed) and adenoma detection rate. RESULTS: In modified intention-to-treat analysis, of 1,031 subjects (age: 59.1 ± 9.8 years; 49.9% male), 510 underwent CAC vs 523 underwent CC with no significant differences in age, gender, ethnicity, or colonoscopy indication between the 2 groups. CAC led to a significantly higher APC compared with CC: 0.99 ± 1.6 vs 0.85 ± 1.5, P = 0.02, incidence rate ratio 1.17 (1.03–1.33, P = 0.02) with no significant difference in the withdrawal time: 11.28 ± 4.59 minutes vs 10.8 ± 4.81 minutes; P = 0.11 between the 2 groups. Difference in positive predictive value of a polyp being an adenoma among CAC and CC was less than 10% threshold established: 48.6% vs 54%, 95% CI −9.56% to −1.48%. There were no significant differences in adenoma detection rate (46.9% vs 42.8%), advanced adenoma (6.5% vs 6.3%), sessile serrated lesion detection rate (12.9% vs 10.1%), and polyp detection rate (63.9% vs 59.3%) between the 2 groups. There was a higher polyp per colonoscopy with CAC compared with CC: 1.68 ± 2.1 vs 1.33 ± 1.8 (incidence rate ratio 1.27; 1.15–1.4; P < 0.01). DISCUSSION: Use of a novel AI detection system showed to a significantly higher number of adenomas per colonoscopy compared with conventional high-definition colonoscopy without any increase in colonoscopy withdrawal time, thus supporting the use of AI-assisted colonoscopy to improve colonoscopy quality (ClinicalTrials.gov NCT04979962).

Funder

FUJIFILM Holdings America Corporation

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Maximizing scarce colonoscopy resources: the crucial role of stool-based tests;JNCI: Journal of the National Cancer Institute;2024-02-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3